|
Verona Pharma announces positive results from mild asthma study
Trading Markets (press release) Verona Pharma plc, a biotechnology company, has completed a successful trial of higher doses of its lead respiratory drug, RPL554, in patients with mild asthma. The randomized, blinded trial, with placebo control, took place in Leiden, The Netherlands, … |
View full post on asthma – Google News